Skip to main content
. 2024 May 1;50(3):187–192. doi: 10.5152/tud.2024.24032

Table 1.

Clinical Demographics of 32 Patients Who were Diagnosed with Liposarcoma

Variables Total
(N = 32)
HU < 20
(N = 18)
HU ≥ 20
(N = 14)
P
Age, year 73 [59-78] 69 [53-76] 77 [70-79] .03
Male 19 (59) 9 (50) 10 (71) .29
Body mass index, kg/m2 20.4 [18.5-22.4] 20.2 [18.5-22.9] 21.0 [17.7-22.6] .75
ECOG-PS .03
 0 19 (59) 14 (78) 5 (36)
 1 13 (41) 4 (22) 9 (64)
Charlson Comorbidity Index 0 [0-2] 0 [0-0] 1.5 [0-2] .03
Maximum transverse diameter of tumor, mm 124 [85-180] 144 [85-197] 105 [82-146] .20
Pathological type
 Dedifferentiated 16 (50) 7 (39) 9 (64) .15
 Well-differentiated 11 (34) 10 (56) 1 (7) .005
 Myxoid 3 (9) 0 3 (21) .07
 Pleomorphic 2 (6) 1 (6) 1 (7) 1.00
Primary site
 Retroperitoneal 25 (78) 14 (78) 11 (79) 1.00
 Mediastinal 1 (3) 0 (0) 1 (7) .44
 Mesentery 3 (9) 1 (6) 2 (14) .57
 Femoral region 3 (9) 3 (16) 0 (0) .24
Recurrence 15 (47) 5 (28) 10 (71)
Overall death 6 (19) 1 (6) 5 (36)

Values in numbers (%) or median [interquartile range].

ECOG-PS, Eastern Cooperative Oncology Group performance status.